Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2007-05-17
2010-06-15
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07737185
ABSTRACT:
The present invention relates to the use of compositions comprising trans-clomiphene for treating wasting, especially a loss of muscle mass. The invention is also directed to methods for treating wasting in a patient with chronic obstructive pulmonary disorder. The present invention is also directed to methods for treating hypogonadism in males with chronic obstructive pulmonary disorder.
REFERENCES:
patent: 4061733 (1977-12-01), Gunjikar
patent: 4820736 (1989-04-01), Jensen et al.
patent: 4894373 (1990-01-01), Young
patent: 5728688 (1998-03-01), Labrie
patent: 5861389 (1999-01-01), Radlmaier
patent: 6017964 (2000-01-01), MacLean et al.
patent: 6096338 (2000-08-01), Lacy
patent: 6126969 (2000-10-01), Shah
patent: 6129933 (2000-10-01), Oshlack
patent: 6143353 (2000-11-01), Oshlack
patent: 6190591 (2001-02-01), Van Lengerich
patent: 6221399 (2001-04-01), Rolfes
patent: 6248363 (2001-06-01), Patel
patent: 6291505 (2001-09-01), Huebner et al.
patent: 6342250 (2002-01-01), Masters
patent: 6391920 (2002-05-01), Fisch
patent: 6583129 (2003-06-01), Mazer et al.
patent: 6600010 (2003-07-01), Mao et al.
patent: 6638528 (2003-10-01), Kanios
patent: 6645974 (2003-11-01), Hutchinson et al.
patent: 6653297 (2003-11-01), Hodgen
patent: 6685957 (2004-02-01), Bezemer et al.
patent: 6743448 (2004-06-01), Kryger
patent: 7105679 (2006-09-01), Kanojia et al.
patent: 2002/0120012 (2002-08-01), Fisch
patent: 2002/0183296 (2002-12-01), Dudley et al.
patent: 2004/0097597 (2004-05-01), Podolski et al.
patent: 2004/0171697 (2004-09-01), Podolski et al.
patent: 2004/0220154 (2004-11-01), Kryger
patent: 2004/0241224 (2004-12-01), Podolski et al.
patent: 2006/0269611 (2006-11-01), Steiner et al.
patent: 2001261684 (2001-12-01), None
patent: 0206021 (1988-08-01), None
patent: 0430388 (1991-06-01), None
patent: 0888775 (1999-07-01), None
patent: 1829534 (2006-03-01), None
patent: 4-312522 (1992-11-01), None
patent: WO 95/35093 (1995-12-01), None
patent: WO 01/34117 (2001-05-01), None
patent: WO 01/91744 (2001-12-01), None
patent: WO 03/005954 (2003-01-01), None
patent: WO 03/005954 (2003-01-01), None
patent: WO 03/026568 (2003-04-01), None
patent: WO 03/072092 (2003-09-01), None
patent: WO 2006/019916 (2006-02-01), None
patent: WO 2006/084153 (2006-08-01), None
patent: WO 2006/102232 (2006-09-01), None
patent: WO 2007/019165 (2007-02-01), None
patent: WO 2009/051908 (2009-04-01), None
Laghi et al. (Am J Respir Crit Care, Med vol. 171, pp. 598-605, 2005).
Debigare et al. (Am. J. Respir. Crit. Care Med., vol. 165, No. 9, 2001, pp. 1712-1717).
Casaburi et al. (Am J Respir Crit Care Med. vol. 170, pp. 870-878, 2004).
Banner A. S. (Lancet, vol. 354, Aug. 7, 1999, pp. 440-441).
Vippagunta (Adv. Drug Del. Rev., 2001, vol. 48, 2001, pp. 3-26.
ACCE Clinical Practice Guidelines for the Evaluation and Treatment of Hypogonadism in Adult Male Patients (1996).
Agarwal, et al., “Male Sexual Dysfunction After Stroke,” J Assoc. Physicians India, vol. 37, No. 8, pp. 505-507 (1989).
Barg, P., et al., “Male Factor: Clinical Evaluation of the Semen Analysis,” Infert. Reprod. Med. Clin. North Amer., vol. 2, pp. 333-340 (1991).
Bartsch, G., “The Effect of Antiestrogen, Antiandrogen, and the Prolactin Inhibitor 2 Bromo-'alpha!-ergocriptine on the Stromal Tissue of Human Benign Prostatic Hyperplasia. Correlation of Sterological Data and Plasma Hormones,” Database Embase; Elsevier Science Publishers, Amsterdam, NL, 1981, vol. 18, No. 4, pp. 308-312.
Bhasin, S., et al., J. Clin Endocrin, Metabol., vol. 91, pp. 1995-2010 (2006).
Brody, J., “Sperm Found Especially Vulnerable to Environment,” The New York Times, Mar. 10, 1981.
Broulik, P.D., “Tamoxifen Prevents Bone Loss in Castrated Male Mice,” Hormone and Metabolic Research, Thieme-Stratton, Stuttgart, DE, vol. 32, No. 5, pp. 181-184 (2000) XP009041862.
Burghardt, et al., “Gap Junction Modulation in Rat Uterus. III. Structure-Activity Relationships of Estrogen Receptor-Binding Ligands on Myometrial and Serosal Cells,” Biol. Reprod. vol. 36, No. 3, pp. 741-751 (1977).
Chang, Ching-Fong, et al., Aquaculture, vol. 101, pp. 329-36 (1992).
Drew, A., “Letter: Possible Teratogenic Effect of Clomifene,” Developmental Medicine and Child Neurology, vol. 16, No. 2, pp. 276 (1974).
Editions Du Vidal Ed - Editions Du Vidal: Vidal 1997; Dictionnaire Vidal 1997, Paris, FR, p. 1161 XP002150196.
Eil, “Ketoconazole Binds to the Human Androgen Receptor,” Harm Metab Res., vol. 24, No. 8, pp. 367-370 (1992).
Elanjian, Sona I., “Clomiphene for Male Infertility,” Journal of Pharmacy Technology, vol. 12, No. 3, pp. 102-104 (1996).
EP Supplementary Search Report of EP 02748104 dated Jun. 24, 2005.
EP Supplementary Search Report of EP 06720243 dated Aug. 6, 2008.
EP Supplementary Search Report of EP 06738985 dated Aug. 15, 2008.
EP Supplementary Search Report of EP 06800648 dated Jul. 21, 2008.
Epstein, “Clomiphene Treatment in Oligospermic Infertile Males,” Fertility and Sterility, vol. 28, No. 7, pp. 741-745 (1977).
Excerpt on www.medscape.com from Drug Ther. Perspect., vol. 10, pp. 1-5 (1997).
Garg, Abhimanyu, “Medical progress: Acquired and Inherited Lipodystrophies,” New England Journal of Medicine, vol. 35, No. 12, pp. 1231-1232 (2004).
Glasier, A., et al., “A Comparison of the Effects on Follicular Development Between Clomiphene Citrate its Two Separate Isomers and Spontaneous Cycles,” Human Reproduction, vol. 4, No. 3, pp. 252-256 (1989).
Grinenko, et al., Khimiko-farmatsevticheskii Zhurnal, vol. 23, No. 1, pp. 123-126 (1989).
Guay, A., et al., Internet!. J. Ompot. Res., vol. 15, pp. 156-165 (2003).
Guzick, D., et al., “Sperm Morphology, Motility and Concentration in Fertile and Infertile Men,” N. Engl. J. Med., vol. 345, pp. 1388-1393 (2001).
Hanus, M., et al., “Antiestrogens (Tamoxifen) in the Alternative Therapy of Benign Prostatic Hyperplasial,” US National Library of Medicine, Bethesda, MD, Databse Medline, vol. 72, No. 7, pp. 316-318 (1993).
Hayashi, Norio, et al., Hinyokika Kiyo (Acta Urologica Japonica), vol. 34, No. 5, pp. 847-50 (1988) with English translation.
Herzog, A. G., “Reproductive Endocrine Considerations and Hormonal Therapy for Men with Epilepsy,” Epilepsia, Raven Press Ltd., New York, US (1991), vol. 32, No. Suppl. 6, pp. S34-S37.
International Preliminary Examination Report of PCT/US02/21524 dated Mar. 3, 2006.
International Preliminary Report on Patentability of PCT/US05/02500 dated Jan. 16, 2007.
International Preliminary Report on Patentability of PCT/US06/003882 dated Aug. 7, 2007.
International Preliminary Report on Patentability of PCT/US06/030053 dated Feb. 5, 2008.
International Preliminary Report on Patentability of PCT/US06/10022 dated Sep. 25, 2007.
International Search Report of PCT/US02/21524 dated Jun. 18, 2003.
International Search Report of PCT/US06/003882 dated Aug. 14, 2006.
International Search Report of PCT/US06/10022 dated Jan. 10, 2007.
International Search Report of PCT/US06/30053 dated Dec. 22, 2006.
International Search Report of PCT/US08/075433 dated Dec. 19, 2008.
International Search Report of PCT/US09/063621 dated Dec. 28, 2009.
Jones, T. Hugh., “Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome,” European Urology Supplements, vol. 6, pp. 847857 (2007).
Kadioglu, et al., Treatment of Idiopathic and Postvaricocelectomy Oligozoospermia with Oral Tamoxifen Citrate, BJU Int., vol. 83, No. 6, pp. 646-648 (1999).
Ke, H. Zhu, et al., “Lasofoxifene, A Selective Estrogen Receptor Modulator, Prevents Bone Loss Induced by Aging and Orchidectomy in the Adult Rat,” Endocrinology, vol. 141, No. 4, pp. 1338-1344 (2000) XP001170303.
Kidd, S., et al., “Effects of male age on semen quality and fertility: a review of the literature,” Fertility and Sterility, vol. 75, pp. 237-248 (2001).
Kotoulas, et al., “Tamoxifen Treatment in Male Infertility. I. Effect on spermatozoa,ȁ
Podolski Joseph S.
Wiehle Ronald
Howrey LLP
Kwon Brian-Yong S
Repros Therapeutics Inc.
LandOfFree
Methods and compositions with trans -clomiphene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions with trans -clomiphene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions with trans -clomiphene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219240